Guard Therapeutics International AB – Rights Issue of shares of approximately SEK 150 million

Access to the information and documents on this portion of the website is restricted for regulatory reasons. We request that you complete all fields below in order to access this information. This personal data will not be retained by us and will be requested of you each time you seek to access this restricted information. They must be true and accurate.